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Abstract
Background: The Global Forum 2015 panel session dialogue entitled “From evidence to policy – thinking outside
the box” was held on 26 August 2015 in the Philippines to debate why evidence was not fully translated into policy
and practice and what could be done to increase its uptake. This paper reports the reasons and possible actions for
increasing the uptake of evidence, and highlights the actions partners could take to increase the use of evidence in
the African Region.
Discussion: The Global Forum 2015 debate attributed African Region’s low uptake of evidence to the big gap
in incentives and interests between research for health researchers and public health policy-makers; limited
appreciation on the side of researchers that public health decisions are based on multiple and complex
considerations; perception among users that research evidence is not relevant to local contexts; absence of
knowledge translation platforms; sub-optimal collaboration and engagement between industry and research
institutions; lack of involvement of civil society organizations; lack of engagement of communities in the
research process; failure to engage the media; limited awareness and debate in national and local parliaments
on the importance of investing in research and innovation; and dearth of research and innovation parks in
the African Region.
(Continued on next page)
* Correspondence: muthurijoses@yahoo.com
1Health Systems and Services Cluster, World Health Organization, Regional
Office for Africa, B. P. 06, Brazzaville, Congo
Full list of author information is available at the end of the article
© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Kirigia et al. BMC Health Services Research 2016, 16(Suppl 4):215
DOI 10.1186/s12913-016-1453-z
(Continued from previous page)
Conclusion: The actions needed in the Region to increase the uptake of evidence in policy and practice
include strengthening NHRS governance; bridging the motivation gap between researchers and health
policy-makers; restoring trust between researchers and decision-makers; ensuring close and continuous
intellectual intercourse among researchers, ministry of health policy-makers and technocrats during the life
course of research projects or programmes; proactive collaboration between academia and industry; regular
briefings of civil society, media, relevant parliamentary committees and development partners; development of
vibrant knowledge translation platforms; development of action plans for implementing research
recommendations, preferably in the context of the Sustainable Development Goals; and encouragement of
competition on NHRS strengthening and research output and uptake among the countries using a barometer
or scorecard to review their performance at various regional ministerial forums and taking into account the
lessons learned from the MDG period.
Keywords: National health research systems, Knowledge translation, Support of research, Diffusion of
innovation, MDGs and SDGs
Background
The purposes of this paper are to summarise the pro-
gress made towards the achievement of the health-
related Millennium Development Goals (MDGs) and
in strengthening the national health research systems’
(NHRS) governance in the World Health Organization
(WHO) African Region; debate the reasons for the low
uptake of evidence in public health policy and practice
and the possible actions for increasing its uptake; and
highlight what partners could do to increase the use of
evidence in the Region.
Majority of the countries in the Region had not
achieved most of the health and health-related MDGs
1, 4, 5, 6 and 7 by the end of 2015. Of the 47 countries
in the Region, 31 had not achieved target 4A on redu-
cing child mortality, 41 had not attained target 5A on
reducing maternal mortality, 35 failed to achieve target
6B on reducing malaria incidence, 18 had not met tar-
get 6C on reducing tuberculosis incidence, and 3 had
not achieved target 6A on reducing HIV incidence [1].
Similarly, most of the countries did not attain the
MDGs related to the broader determinants of health.
For instance, 30 countries had not achieved the target
of reducing the number of underweight children aged
less than 5 years, and MDG 7’s targets of increasing the
coverage of water provision and sanitation had not been
achieved by 24 countries and 39 countries, respectively.
The inability to achieve the health and health-related
MDGs has been attributed to the persisting weakness
of the national and sub-national health systems, the
systems that address the social determinants of health,
and the national health research systems (NHRS) [1].
Even before concluding the health MDG agenda, the
countries are forced to brace themselves to transition
to the post-2015 Sustainable Development Goals’
(SDGs) agenda [2], whose SDG 3 is on ensuring healthy
lives and promoting the wellbeing of all at all ages, and
target 3.8 is on achieving universal health coverage
(UHC), including providing financial risk protection
and access to quality essential health care services and
to safe, effective, quality and affordable essential medi-
cines and vaccines for all. Movement towards UHC en-
tails simultaneous progress in the expansion of the
range of health and health-related services available,
the covered proportion of the cost of those services,
and the proportion of the population covered [3, 4].
The World health report 2013 [5] illustrates with 12
case studies that research illuminates the path to UHC
and to better health. Nine of the case studies are on the
diversity of the problems tackled using randomised con-
trolled trials: insecticide-treated mosquito nets to reduce
childhood mortality in 22 sub-Saharan African countries;
antiretroviral therapy to prevent sexual transmission of
HIV in Africa, Asia, Latin America and North America;
zinc supplementation to reduce pneumonia and diarrhoea
in young children in Bangladesh; telemedicine to improve
the quality of paediatric care in Somalia; new diagnostics
(Xpert MTB/RIF) for tuberculosis in Azerbaijan, India,
Peru and South Africa; the “polypill” to reduce deaths from
cardiovascular disease in India; combination treatment
with sodium stibogluconate (SSG) and paromomycin com-
pared to SSG monotherapy for visceral leishmaniasis in
Ethiopia, Kenya, Sudan and Uganda; task shifting in the
scaling up of interventions to improve child survival in
Bangladesh, Brazil, Tanzania and Uganda; and insur-
ance in the provision of accessible and affordable health
services in Mexico. The other three case studies are on
operational research that led to improved access to
emergency obstetrics care in rural Burundi, conditional
cash transfers to improve the use of health services and
health outcomes in low and middle income countries,
and affordable health care in ageing populations in the
Czech Republic, Germany, Hungary, the Netherlands
and Slovenia [5].
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SDG 3 is much more ambitious than the outgoing
health MDGs. The process of planning and developing
country road maps for scaling up health and health-
related policy and programmatic interventions for UHC
requires generation and utilisation of contextualised evi-
dence. Examples of the evidence needed include infor-
mation on the burden of disease; baseline population
coverage of health and health-related interventions, in-
cluding household survey and health behaviour data;
effectiveness and cost-effectiveness of interventions
and delivery models; packages of essential health ser-
vices to be accessed by everyone in need; economic
feasibility of prepaid health financing mechanisms; and
sociocultural, political and professional feasibility of
the services [5]. This kind of evidence will not be forth-
coming or available where NHRS are not functional
[6]. That is why research, innovation and domestic
technology development are prominent targets of SDG
9, which is on building resilient infrastructure, promot-
ing inclusive and sustainable industrialisation and fos-
tering innovation.
To stand a fair chance of attaining SDG 3, African Re-
gion countries need to have functional NHRS that facili-
tate the production and use of pertinent evidence in
public health policy and practice. Between 2000 and
2014, the Region accounted for only 1.3 % of the global
output of scientific publications [7], which is not com-
mensurate with its 12 % share of the global population.
The low research output is partially attributable to the
weak NHRS governance. For example, of the 47 coun-
tries in the Region, 24 have not defined their health re-
search policy at all, 28 have no laws or regulations
governing research, 25 have not developed a strategic re-
search plan and 22 lack a national priority agenda on re-
search for health [8]. The low research output partially
accounts for the dearth of development and innovation
of health restoring or sustaining products [9]. Weak-
nesses in NHRS are exacerbated by the significant chal-
lenges in training and retaining of academic, scientific or
research human resources for research for health and
biomedical purposes.
Discussion
Forum 2015 session dialogue method
The Global Forum on Research and Innovation for
Health 2015 took place in Manila, Philippines, 24–27
August 2015. It was co-organised by the Council on
Health Research for Development (COHRED), the
Philippine Department of Science and Technology, the
Philippine Department of Health and the Philippine
Council for Health Research and Development. Its aim
was to identify research and innovation solutions to
the world’s unmet health needs. The programme had
two pillars focusing on increasing the effectiveness of
research and innovation for health and on the role of
research and innovation. The proceedings were orga-
nised under six broad themes: social accountability for
research and innovation for health, increasing invest-
ment for research and innovation for health, country-
driven capacity building for research and innovation
for health, research and innovation for food and nutri-
tion safety and security, research and innovation to safe-
guard health in megacities and research and innovation in
disaster preparedness.
This paper reports on the 75-minute debate that took
place on 26 August 2015 in the session entitled “From
evidence to policy – thinking outside the box”. The de-
bate focused on how to improve the uptake and use of
research-derived evidence in creating better health pol-
icies and practices and how to get health in all policies.
The session started with introductions of the five key-
note speakers by the moderator, who was from the
World Bank. The speakers were from the University
Hospital Farhat Hached in Tunisia, Institute of Global
Health Innovation of the Imperial College London,
WHO Regional Office for Africa, WHO Regional Office
for Europe, and Pan American Health Organization/
WHO Regional Office for the Americas. The speakers
took an average of six minutes. The floor was then
opened for questions and comments from the audience.
The speakers noted the questions and comments, and
subsequently responded to them. The moderator pro-
vided a summary of emerging recommendations at the
end of the session.
The session was attended by high level representatives
from governments including policy-makers and senior
technical staff from the ministries of education, science
and technology, environment and health; civil society or-
ganisations (CSOs); international organisations; private
for-profit sector; private not-for-profit sector; academic
and research institutions, including faculty members and
students; and academic journal editors, including the
Asia Pacific Association of Medical Editors, Nature Part-
ner Journals and British Medical Journal [BMJ] Open.
Approximately 300 people participated in the session.
A conscious effort has been made by the authors to
buttress the recommendations from the debate with per-
tinent published literature. The main limitation of the
paper is that the verbatim proceedings were not audio
recorded, so what is reported here is a summary of the
notes taken by the panellists.
Forum 2015 session debate issues
Why the low the uptake of evidence in public health policy
and practice?
The Global Forum 2015 debate attributed African Re-
gion’s low uptake of evidence in public health policy and
practice to a number of factors.
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First, there is a big gap in incentives and interests be-
tween research for health researchers and public health
policy-makers. Researchers and policy-makers are
known to pursue different interests, which in itself pre-
sents a discord in the uptake of research evidence. Choi
et al. [10] argue that the discord is premised on differ-
ences in mentalities and imperatives of scientists and
policy-makers, among which are pursuance of different
goals and career paths, perception of time, lack of mu-
tual trust and respect, and different attitudes towards re-
search [10]. While researchers attach a lot of importance
to scientific rigour, policy-makers look for important,
timely information from informal evidence-generation
mechanisms like real experiences that can drive
decision-making, considering the political and context-
ual realities [10]. Even with the best of intentions, be-
cause of the nature of the system, researchers end up
being driven by the need to publish to retain their sci-
entific or research jobs and also to merit academic pro-
motion (the so-called publish or perish notion); are
inclined to publish in high impact journals for prestige
among their peers; feed their research into teaching
and learning; work to gain goodwill with research fun-
ders [11, 12]; and earn royalties on intellectual proper-
ties [13, 14]. This is limiting in a number of ways.
Academic journals may not be the best way to dissem-
inate evidence in low income countries, where access to
journals is limited owing to Internet connectivity handi-
caps and cost, the reading culture is weak, literacy levels
are relatively low, and the technical or scientific language
used may not be easily accessible to policy-makers [15].
Policy-makers on their part are forced to do a balan-
cing act in striving to manage enormous – and at times
catastrophic – vested interests and pressure from politi-
cians; donors; professional trade unions; civil society
lobby groups; the community, whose sense has been
heightened by the emergence of patient charters; and
the ministry of health’s priority programmes such as
those on HIV/AIDS, tuberculosis, malaria, maternal and
child health, as well as the ministry of finance’s budget
pressures and limitations. Added to these are the specific
manager’s whims, personal preferences and decision-
making style, which might be influenced by the emotions
of the moment or day [16–19]. Health policy-makers are
always trying to balance scarce resources against un-
limited clinical and public health needs and demands
[20–22], and they need to make timely decisions that
need to consider many contextual issues [19].
Second, there is limited appreciation on the side of re-
searchers that public health decisions are based on mul-
tiple and complex considerations, for example those
related to circumstances of political, economic, social,
cultural, and windows-of-opportunity nature, among
which evidence may or may not necessarily occupy a
prominent place [19, 23, 24]. For example, Hennink and
colleagues [25] caution against research recommenda-
tions that ignore affordability concerns, while Hum-
phreys and Piot [26] caution against recommendations
that are contrary to social norms and recommend
weighing the possible electoral consequences of the dif-
ferent policy options.
Third, there is often the perception among intended
research users, especially policy-makers, that research
evidence is not relevant to local contexts. The perceived
quality and relevance of the research evidence [27, 28],
the credibility of the researchers [29, 30] and the extent
to which evidence resonates with social and cultural
norms and political interests also do impact its uptake in
decision-making [31, 32]. There are instances where
high quality evidence has not been taken up in policy
due to the lack of political support, like the case of med-
ical male circumcision in Uganda [33] or indoor residual
spraying for malaria vector control in Zimbabwe [34].
An additional consideration has been the different time
horizons that underpin scientific research and policy-
making. The decision-makers at times use readily avail-
able, unpublished literature and information from
newspapers to take decisions, whereas scientific re-
search takes time to design, conduct, write, peer review,
publish, and properly summarise and package to be of
use to policy-makers [35].
Fourth, the absence of institutionalised and system-
atic knowledge translation platforms in the majority of
African countries reduces the opportunities for dia-
logue between researchers and policy-makers, which
contributes to the widening of the communication and
trust gaps between the key constituencies and stake-
holders. By the end of 2014, 15 of the 47 countries in
the African Region had a knowledge translation plat-
form to facilitate the uptake of evidence in policy devel-
opment and practice [8]. This represented substantial
improvement in the last decade, but progress remains
insufficient. Institutionalised and systematic knowledge
translation platforms have been deemed helpful where
they exist and are functional, for example in Uganda,
where the malaria treatment policy was changed follow-
ing the generation of evidence from drug efficacy stud-
ies [29], and in Kenya, Malawi and Nigeria, where there
was uptake of evidence from operational research [36].
Fifth, there has been sub-optimal collaboration and
engagement between industry and research institutions,
including universities and other tertiary institutions
across Africa, which negatively affects the quality and
relevance of learning and research and reduces the
chances of translating research findings into product
innovation and development. This likely accounts for
the fact that out of approximately 850 new therapeutic
products (drugs and vaccines) registered worldwide in
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2000–2011, only 37 were indicated for common and ser-
ious diseases such as malaria, tuberculosis, diarrhoeal
diseases, neglected tropical diseases and other diseases
of poverty that disproportionately affect Africa [9].
Sixth, the lack of involvement of CSOs in research, de-
velopment and innovation contributes to the low uptake
of evidence. From the interactions at the Global Forum
2015, it was clear that progressive involvement of CSOs
in research and development within functional NHRS
has catalysed the uptake of evidence in policy and prac-
tice in Asia, Latin America, Europe and North America.
In those continents, CSOs continue to play an important
advocacy role by demanding that public decisions be
based primarily or as much as possible on science and
other relevant evidence. CSO advocacy and lobbying
capacities have not been optimally tapped to further the
uptake of evidence in the Africa Region and in many
cases have been or are being politically suppressed.
Doyle and Patel [37] highlight the inadequate capacity of
CSOs to navigate the political terrain and to influence
policy. Furthermore, the specific challenges faced by
CSOs in low income countries need to be addressed,
among which are weak internal organisations, lack of in-
dependence and varied capacity.
Seventh, the lack of structures to enable meaningful
engagement of communities in the research process has
been highlighted as a major bottleneck to the uptake of
evidence [38, 39]. It was also clear during the Global
Forum 2015 proceedings that in the rest of the world de-
liberate efforts are being made to increase societal/com-
munity awareness of the role of research and innovation
in human development. In many countries, communi-
ties, including patients, are increasingly viewed as active
partners in research. In the best of cases, a culture of
critical enquiry and investigation is encouraged and nur-
tured from childhood to old age and from kindergarten
to postgraduate levels. In the Africa Region community
awareness of and involvement in research for health are
limited, and the research and innovation culture is grow-
ing only slowly, as seen in national research, science and
technology symposia and competitions. There is need
for consciously planned efforts to cultivate research and
innovation awareness among the community and more
importantly to mainstream research and innovation in
student and teacher or lecturer training curricula at all
levels of the national education system.
Eighth, the Global Forum 2015 participants opined
that the absence of an official regional policy and strat-
egy on research for health may hamper development of
NHRS, including the uptake of evidence. Having a re-
gional policy and strategy on research for health for Af-
rica [40] and accurate indicators of progress within the
structure and processes of NHRS will likely result in ac-
tionable research and generation of momentum in
advancing such systems in the countries, as has hap-
pened in other regions [41, 42].
Ninth, researchers in the African Region often fail to
deliberately engage the media over the life course of re-
search projects to create public awareness and to com-
municate research findings and advocate for their use in
decision-making. The media have been shown to be use-
ful in community mobilisation and raising their aware-
ness of evidence, thereby empowering them to demand
that certain proven, cost-effective polices be imple-
mented [43]. The experiences from different regions
shared at the Global Forum 2015 indicated that active
engagement of the media in the life course of research
for health projects has helped to bolster the translation
of evidence into policy, practice and innovation.
Tenth, there seems to be limited awareness and debate
in national and local parliaments across the African Re-
gion on the importance of investing in research and
innovation. This is reflected by the fact that 22 of the 47
countries in the Region do not have a budget line for re-
search for health [8]. So far only two countries have
complied with the recommendation of the Commission
on Health Research and Development and the Algiers
Ministerial Declaration on Research for Health to allo-
cate at least 2 % of the national health sector budget to
health research [44]. The Global Forum 2015 partici-
pants argued that the limited awareness of parliamentar-
ians of the role of research in health and their little
engagement in it might explain the paucity of research
and innovation champions among the countries of the
Africa Region.
Lastly, the low uptake of evidence was attributed also
to the dearth of research and innovation (science) parks
in the African Region. It was clear at the forum that
some Asian and Latin American countries, having drawn
lessons from the industrialised countries of the Organ-
isation for Economic Co-operation and Development,
were investing heavily in the development of research
and innovation parks. Such parks act as magnets for tal-
ent and incubation centres for ideas, some of which find
their way into product development and innovation. In
the African Region, only South Africa and Uganda re-
ported that they were developing such structures.
What can African countries do to increase the uptake of
evidence?
The Global Forum 2015 debate highlighted a number of
actions that were needed to increase the uptake of evi-
dence in policy and practice.
First, strengthen NHRS governance to create an enab-
ling environment for research and innovation. Every
country should ensure that it has a national health re-
search policy, a strategic plan, an agenda for priority re-
search for health and pertinent legislation.
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Second, bridge the gap between researchers and health
policy-makers. It is important for researchers to realise
and acknowledge that they are partly responsible for the
problem of low evidence uptake. To provide incentives
for researchers to conduct research that serves policy,
practice (innovation) and/or product development pur-
poses, it may be beneficial for a national research com-
munity, together with their policy-makers, to devise and
implement a system of weighting the impact of research
articles in terms of their uptake in policy, practice and
product development. For example, an article whose
findings influence public health policy, practice and
product development could be given a score of 1 or
100 %, one that influences policy could be given 0.75 or
75 %, one impacting only public health or clinical prac-
tice could be given 0.5 or 50 %, and one with no impact
on policy, practice or product development could receive
0.25 or 25 %. If developed in a participatory manner and
adopted, such weighting might contribute to the modifi-
cation of the incentive structures and behaviour of re-
searchers to favour research orientations that more
effectively address public health challenges confronting
the Africa Region. Another consideration would be the
development of a prioritised national research agenda in
a participatory manner to ensure that researchers’ and
policy-makers’ interests are aligned.
Third, build trust between researchers and decision-
makers of the kind that was characteristic of such rela-
tionships in most countries in the African Region
around the period of political independence [45, 46].
This will require changing the firmly entrenched nega-
tive perceptions and, indeed, the mind-set. Some coun-
tries have used memorandums of understanding between
research for health institutions and the ministry of health
to build bridges. The memorandums often cover research,
monitoring and evaluation of research, and short-term
(on-the-job) and long-term human resource capacity
strengthening. Institutionally, the establishment of na-
tional academies of science can equally be instrumental in
building bridges of trust, by including as their leading
members scientists and intellectual leaders and recog-
nised policy-makers, politicians and other national
leaders. Such joint forums would subsequently need to
be given public prominence.
Fourth, ensure close intellectual intercourse between
researchers and the ministry of health’s decision-makers
and technocrats during the entire research projects’ life
course. The panellists noted that from their experience,
in situations where that constant engagement exists,
the research recommendations invariably easily find
their way into policy and practice. However, such close
engagement requires investment in money and time,
which ought to be foreseen and factored into the re-
search projects’ cost.
Fifth, introduce regular briefing of CSOs and the
media during a project’s lifecycle, which may increase
the uptake of its research findings and recommenda-
tions. We hasten to add, however, that written media
briefings have proved to be more effective than verbal
briefings, as in some cases these stakeholders have been
found to misrepresent the facts [15].
Sixth, grow and nurture collaboration between academia
(and research institutions) and industry to increase re-
search uptake in innovation and product development.
Lessons from economically developed and emerging econ-
omies indicate that close collaboration between academia
and industry enhances the quality and relevance of teach-
ing, funding for research, overall sustainability of academic
institutions, and volume of research and innovation out-
puts, and increases the rate of translation of such outputs
into product development. At the Global Forum 2015 the
example of Singapore’s research and development and
innovation policies and practice over the last 25 years was
highlighted in this respect. Also, including the most
respected research leaders from industry in the national
academy of sciences has been shown to be an important
long-term capacity-building element in creating a viable
research-academia-industry constituency in a country.
Seventh, researchers in the applied sciences ought to
avoid making research for health recommendations that
are generic, but instead should ensure that their recom-
mendations are feasible, implementable and scalable to
the furthest extent possible. In addition, they should
work with those expected to utilise the evidence to de-
velop action plans that contain SMART (specific, meas-
urable, attainable, relevant and time-bound) actions, cost
estimates, possible sources of funding and names and
roles of persons responsible for their execution.
Eighth, establish inclusive knowledge translation plat-
forms such as the Evidence Informed Policy Network
(EVIPNet) [47]. Such platforms ought to be made up of
multidisciplinary and multi-stakeholder teams, drawing
experts from all the relevant disciplines. In addition, they
should include policy-makers, selected technocrats from
the ministry of health and representatives of civil society,
the media and, to the utmost extent possible, the national
parliament. The role of the platform is to provide inputs
to inform policy options and to create the environment
where these can be discussed with the participation of
relevant stakeholders and where policy-makers can assess
the potential benefits and risks for each policy option and
the feasibility of its implementation, considering the con-
textual issues. Examples of the tools used for this assess-
ment are policy briefs, research syntheses, plans of action
for implementing recommendations/findings, advocacy
for uptake of evidence in decision-making, deliberative di-
alogues, rapid response mechanisms, and technical advice
for policy-makers and implementers of interventions [48].
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Ninth, make health research and innovation a part of
the societies’/communities’ mantra to empower them to
demand that health development decisions be informed
by research evidence.
What can partners do to help African countries increase the
uptake of evidence?
The Global Forum 2015 debates highlighted the actions
that the relevant international partners ought to under-
take to support the implementation of the research-
related recommendations from the various high level
ministerial forums held in Africa.
First, provide technical support for building/strength-
ening NHRS. For example, COHRED has developed
three tools that would help African countries to improve
governance of research. These are (1) a cloud-based re-
search ethics review software called RHInnO Ethics,
which is already being used in 8 African countries and 27
research ethics committees [49]; (2) the Fair Research
Contracting service, which provides legal expertise using
guides, the web and online/telephone or on-site consult-
ing services and course work learning opportunities for re-
search administrators [50]; and (3) the COHRED Fairness
Index, which is a global certification mechanism for safe-
guarding fairness in research contracting [51, 52]. WHO
also provides technical support to Member States for de-
veloping national health research policies, strategic plans,
research agenda, and standards and operational guidelines
for ethics review of health-related research [53, 54], as well
as for training of national research ethics committees [55]
and for implementation of research [56].
Second, support countries to develop human resources
for health research. For example, the Special Programme
for Research and Training in Tropical Diseases (TDR)
has been providing training grants for doctor of philoso-
phy, master’s and fellowship training in product develop-
ment; customised workshops; mentorship and networking
opportunities; and research support to strengthen capacity
in low and middle income countries [57].
Third, support the countries to establish and maintain
knowledge translation and sharing platforms such as
EVIPNet to facilitate the use of research in health
decision-making.
Fourth, global health initiatives and development agen-
cies, including the United Nations agencies, ought to de-
vote at least 5 % of their overall health investment
portfolio to support the strengthening/building of NHRS
[44, 58]. This was a recommendation originally made by
the 1990 Commission on Health Research and Develop-
ment [58] and reiterated in the Algiers Ministerial Dec-
laration on Research for Health [44].
Fifth, it is a fact that, rightly or wrongly, many global
health development partners have significant influence
on African countries’ processes for developing health
policies and plans. This is attributed to the critical reli-
ance of a substantial proportion of African countries on
donor funding for health development, especially for in-
vestment budgets (as opposed to mostly domestically fi-
nanced recurrent budgets), and this does not necessarily
strengthen governance and stewardship by governments
[59]. There is evidence that involving global partners in
the life course of research projects can be helpful in ad-
vocacy for and uptake of findings and recommendations
in national or local health policies and practice [60].
Sixth, provide funding for research on priority prob-
lems identified by the countries and contained in their
national health research agenda or identified at the re-
gional high level ministerial meetings. For instance, both
the Abuja and Accra communiques from the High Level
Ministerial Meetings on Health Research in Africa iden-
tified as research priorities (1) health systems research,
including health policy and human resources research;
(2) infectious diseases such as malaria, tuberculosis,
HIV/AIDS, emerging infections, and neglected tropical
diseases such as African trypanosomiasis, Buruli ulcer,
leishmaniasis and lymphatic filariasis, that require im-
provement in prevention, diagnosis, treatment, control
and surveillance; (3) sexual and reproductive health; (4)
newborn and child health; (5) non-communicable dis-
eases, including cardiovascular disease, diabetes, cancer,
sickle cell disease, injuries and occupational diseases; (6)
malnutrition (undernutrition and obesity); and (7) men-
tal health, including drug and substance abuse [61, 62].
TDR is an example of organisations that support (1) the
development of new tools and implementation research
for infectious diseases of poverty; (2) finding ways of
helping vulnerable populations to develop resilience and
survive climate change; (3) elimination of malaria, vis-
ceral leishmaniasis and onchocerciasis; and (4) training
of community volunteers in remote or low resource set-
tings to diagnose and treat childhood fever-related ill-
nesses like pneumonia, diarrhoea and malaria [57].
Seventh, support regional coordination and South–
South cooperation and networking in research, develop-
ment and innovation for health [62].
Eighth, support the full implementation of the regional
strategy on research for health that was adopted by the
ministers of health from all the 47 WHO African
Member States during the Sixty-fifth WHO Regional
Committee for Africa session [40].
Ninth, encourage competition among countries in
NHRS strengthening and research output and uptake
through the use of regional and sub-regional scorecards
[63]. Reviews of these can be conducted, discussed and
subsequently published at regional, annual or periodic
meetings of such overarching agencies as the African
Academy of Sciences [64], the Association of African
Universities [65], the Inter-University Council of East
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Africa [66], etc. In addition, the NHRS performance
scorecards or league tables could potentially be dis-
cussed at the African Union, regional economic commu-
nities and WHO Regional Committee forums to further
stimulate debate and healthy competition.
Conclusions
A majority of African Region countries will not achieve
the health and health-related MDGs owing to weak-
nesses in their national and local health systems, systems
that address the social determinants of health, and
NHRS. The weak NHRS across Africa account for the
low research for health output and its uptake in public
health policy and practice. The debate at the Global
Forum 2015 attributed the low uptake of evidence partly
to weak NHRS governance; the incentive gap between
researchers and policy-makers; a deficit in trust, confi-
dence and respect between researchers and policy-
makers [67]; a lack of appreciation on the side of re-
searchers that public health decisions are a function of
many factors; the absence of knowledge translation
platforms in most countries; and sub-optimal collabor-
ation and engagement between researchers and re-
search institutions on the one hand and industry,
communities, CSOs, the media and parliamentarians
on the other hand.
Some of the actions suggested during the debates for
increasing the uptake of evidence in policy and practice
include (1) strengthening NHRS governance; (2) bridg-
ing the gap in motivation between researchers and
health policy-makers; (3) restoring trust between re-
searchers and decision-makers; (4) ensuring close intel-
lectual intercourse between researchers and ministry of
health policy-makers and technocrats during the entire
life course of a research project or programme; (5) fos-
tering collaboration between academia and industry; (6)
regularly briefing civil society, the media, relevant parlia-
mentary committees and development partners; (7) de-
veloping vibrant knowledge translation platforms; (8)
developing action plans for implementing research rec-
ommendations; and (9) encouraging competition on
NHRS strengthening and research output and uptake
among countries using a barometer or scorecard. Peer
review of the scorecard could take place at various re-
gional economic community forums, the African Union
and the Regional Committee’s ministers of health ses-
sions, as well as at regional academic, scientific and re-
search meetings.
These actions will not happen in a vacuum. The global
Strategy on Research for Health approved in 2010 by the
World Health Assembly already is giving direction and
is relevant to some of the existing platforms and efforts
that have led to progress in Africa. For example, the de-
velopment of the EVIPNet platform, the Regional East
African Community Health Policy Initiative [68] and the
International Clinical Trials Registry Platform and the
subsequent Pan African Clinical Trial Registry that feeds
into it are all linked to the WHO strategy, and resulted
from the deliberations held in the WHO African Advis-
ory Committee on Research for Health. WHO work also
builds upon the huge and commendable contributions
made by COHRED over more than two decades in the
areas of national health research systems, research for
health and ethical review systems [69]. The adoption of
the African Region Strategy on Research for Health by
the Sixty-fifth Session of the WHO Regional Committee
for Africa in November 2015 was an opportunity to re-
gain momentum and seek further adoption of key strat-
egies that contribute to better production and use of
research for health.
Abbreviations
COHRED, Council on Health Research for Development; CSO, civil society
organisation; EVIPNet, Evidence-informed Policy Network; MDG, Millennium
Development Goal; NHRS, national health research systems; SDG, Sustainable
Development Goal; TDR, Special Programme for Research and Training in Tropical
Diseases; UHC, universal health coverage; WHO, World Health Organization
Acknowledgements
COP was the moderator and JMK, OP, LGC and HG were panellists in the
Global Forum 2015 session entitled “From evidence to policy – thinking
outside the box”. The moderator (COP) and panellists (JMK, LGC, HG) are
grateful to the COHRED leadership for the invitation to participate at the
Global Forum 2015. CI was the organiser of the Global Forum 2015. We do
thank all those who participated in the Panel session for the pertinent
questions and comments. We also owe gratitude to God for the successful
session, safe return to our work and home bases and inspiration. This article
contains the views of the authors only and does not represent the decisions
or the stated policies of the organisations they work for or are affiliated to.
Declarations
This article has been published as part of BMC Health Services Research Volume
16 Supplement 4, 2016: Health policy dialogue: lessons from Africa. The full
contents of the supplement are available online at http://bmchealthservres.
biomedcentral.com/articles/supplements/volume-16-supplement-4.
Availability of data and materials
Not applicable.
Authors’ contributions
JMK, COP, LGCA, HG, CI and JNO contributed equally to the writing of this
paper. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics and approval and consent to participate
The study involved only a review of published literature and documents in
the public domain and as such did not require ethical clearance from the
WHO Regional Office Africa’s Ethics Review Committee.
Author details
1Health Systems and Services Cluster, World Health Organization, Regional
Office for Africa, B. P. 06, Brazzaville, Congo. 2The World Bank, Washington,
D.C, USA. 3Research Promotion and Development, Pan American Health
Organization/World Health Organization (PAHO/WHO), Washington, D.C,
USA. 4Department of Epidemiology, University Hospital Farhat Hached,
Kirigia et al. BMC Health Services Research 2016, 16(Suppl 4):215 Page 312 of 366
Sousse, Tunis, Tunisia. 5Council on Health Research for Development
(COHRED), Geneva, Switzerland.
Published: 18 July 2016
References
1. WHO. World health statistics 2015. Geneva: WHO; 2015.
2. United Nations Sustainable Development Solutions Network (UNSDSN).
Health in the framework of sustainable development. Technical Report for
the Post-2015 Development Agenda. New York: United Nations; 2014.
3. Sambo LG, Kirigia JM. Investing in health systems for universal health
coverage in Africa. BMC Int Health Hum Rights. 2014;14:28. http://www.
biomedcentral.com/1472-698X/14/28.
4. WHO. World health report 2010 – health systems financing: the path to
universal coverage. Geneva: WHO; 2010.
5. WHO. World health report 2013 – Research for universal health coverage.
Geneva: WHO; 2013.
6. Kirigia JM, Kathyola DD, Muula AS, Ota MM. National health research system
in Malawi: Dead, moribund, tepid or flourishing? BMC Health Serv Res. 2015;
15:126. www.biomedcentral.com/1472-6963/15/126.
7. Uthman OA, Wiysonge CS, Ota MO, Nicol M, Hussey GD, Ndumbe PM,
Mayosi BM. Increasing the value of health research in the WHO African
Region beyond 2015 – reflecting on the past, celebrating the present
and building the future: A bibliometric analysis. BMJ Open 2015.
doi:10.1136/bmjopen-2014-006340.
8. Kirigia JM, Ota MO, Motari M, Bataringaya JE, Mouhouelo P. National health
research systems in the WHO African Region: Current status and the way
forward. Health Research Policy and Systems. 2015;13:61. doi:10.1186/
s12961-015-0054-3. http://www.health-policy-systems.com/content/13/1/61.
9. Pedrique B, Strub-Wourgaft N, Claudette Some C, Olliaro P, Trouiller P,
Ford N, Pécoul B, Bradol J-H. The drug and vaccine landscape for
neglected diseases (2000–11): A systematic assessment. Lancet Glob
Health. 2013;1:e371–9. http://dx.doi.org/10.1016/S2214-109X(13)70078-0.
10. Choi BCK, Pang T, Lin V, Puska P, Sherman G, Goddard M, Ackland MJ,
Sainsbury P, Stachenko S, Morrison H, Clottey C. Can scientists and policy
makers work together? J Epidemiol Community Health. 2005;59:632–7.
11. Caplan N. The two-communities theory and knowledge utilization. Am
Behav Sci. 1979;22(3):459–70.
12. Siegal D, Waldman D, Atwater L, Link A. Toward a model of effective
transfer of scientific knowledge from academicians to practitioners:
Qualitative evidence from commercialization of university technologies. J
Eng Technol Manag. 2004;21:115–42.
13. Closs L, Ferreira G, Brasil V, Sampaio C, Perin M. What motivates Brazilian
academic researchers to transfer technology? J Technol Manag Innov. 2013;
8(4):79–90.
14. Baldini N, Grimaldi R, Sobrero M. To patent or not to patent? A survey of
Italian inventors on motivations, incentives and obstacles to university
patenting. Scientomerics. 2005;70(2):333–54.
15. Nabyonga–Orem J, Marchal B, Mafigiri DK, Ssengooba F, Macq J, Da Silveira
VC, Criel B. Perspectives on the role of stakeholders in knowledge
translation in health policy development in Uganda. BMC Health Serv Res.
2013;13:324. doi:10.1186/1472-6963-13-324. http://www.biomedcentral.com/
1472-6963/13/324.
16. Hyder A, Corluka A, Winch PJ, El-Shinnawy A, Ghassany H, Malekafzali H,
Lim M-K, Mfutso-Bengo J, Segura E, Ghaffar A. National policy-makers
speak out: Are researchers giving them what they need. Health Policy
Plan. 2011;26:73–82.
17. Jones E, Kreuter M, Pritchett S, Matulionis RM, Hann N. State policy makers:
What’s the message and who’s listening. Health Promot Pract. 2006;7(3):280–6.
18. Soare L. Creating a link between academic research and policy making.
Europolity. 2013;7(2):89–102.
19. Head B, Ferguson M, Cherney A, Boreham P. Are policy-makers interested in
social research? Exploring the sources and uses of valued information
among public servants in Australia. Policy and Society. 2014;33:89–101.
20. Mooney GH. Economics, medicine and health care. London: Financial Times
Prentice Hall; 2003.
21. Kirigia JM. Efficiency of health system units in africa: a data envelopment
analysis. Nairobi: University of Nairobi Press; 2013.
22. Kirigia JM. Economic evaluation of public health problems in sub-Saharan
Africa. Nairobi: University of Nairobi Press; 2009.
23. Haynes RB, Devereaux PJ, Guyatt GH. Physicians’ and patients’ choices in
evidence based practice – evidence does not make decisions, people do.
BMJ. 2002;324:1350.
24. Haynes B, Haines A. Barriers and bridges to evidence based clinical practice.
BMJ. 1998;317:273.
25. Hennink M, Stephenson R. Using research to inform health policy: barriers and
strategies in developing countries. J Health Commun. 2005;10(2):163–80.
26. Humphreys K, Piot P. Scientific evidence alone is not sufficient basis for
health policy. BMJ. 2012;344:e1316.
27. Syed SB, Hyder AA, Bloom G, Sundaram S, Bhuiya A, Zhenzhong Z, Kanjilal
B, Oladepo O, Pariyo G, Peters DH. Exploring evidence-policy linkages in
health research plans: a case study from six countries. Health Res Policy
Syst. 2008;6:4.
28. Aaserud M, Lewin S, Innvaer S, Paulsen EJ, Dahlgren AT, Trommald M,
Duley L, Zwarenstein M, Oxman AD. Translating research into policy and
practice in developing countries: a case study of magnesium sulphate for
pre-eclampsia. BMC Health Serv Res. 2005;5:68.
29. Nabyonga-Orem J, Ssengooba F, Macq J, Criel B. Malaria treatment policy
change in Uganda: What role did evidence play? Malar J. 2014;13:345.
30. Sevene E, Lewin S, Mariano A, Woelk G, Oxman AD, Matinhure S, et al.
System and market failures: The unavailability of magnesium sulphate for
the treatment of eclampsia and pre-eclampsia in Mozambique and
Zimbabwe. BMJ. 2005;331(7519):765–9.
31. Moat KA, Lavis JN, Abelson J. How contexts and issues influence the use of
policy relevant research syntheses: A critical interpretive synthesis. Milbank
Q. 2013;91(3):604–48.
32. Hutchinson E, Droti B, Gibb D, Chishinga N, Hoskins S, Phiri S, et al.
Translating evidence into policy in low-income countries: Lessons from co-
trimoxazole preventive therapy. Bull World Health Organ. 2011;89(4):312–6.
33. Ssengooba F, Atuyambe L, Kiwanuka SN, Puvanachandra P, Glass N, Hyder
AA. Research translation to inform national health policies: Learning from
multiple perspectives in Uganda. BMC Int Health Hum Rights. 2011;11 Suppl
1:S13. http://www.biomedcentral.com/1472-698X/11/S1/S13.
34. Cliff J, Lewin S, Woelk G, Fernandes B, Mariano A, Sevene E, et al. Policy
development in malaria vector management in Mozambique, South Africa
and Zimbabwe. Health Policy Plan. 2010;25(5):372–83.
35. Dabelko GD. Speaking their language: How to communicate better with
policymakers and opinion shapers – and why academics should bother in
the first place. Int Environ Agreements. 2005;5:381–6.
36. Theobald S, Taegtmeyer M, Squire SB, Crichton J, Simwaka BN, Thomson
R, et al. Towards building equitable health systems in sub-Saharan Africa:
Lessons from case studies on operational research. Health Res Policy Syst.
2009;7:26.
37. Doyle C, Patel P. Civil society organisations and global health initiatives:
Problems of legitimacy. Soc Sci Med. 2008;66(9):1928–38.
38. Bowen S, Martens P. Demystifying knowledge translation: Learning from the
community. J Health Serv Res Policy. 2005;10(4):203–11.
39. Pollard A, Court J. How civil society organisations use evidence to influence
policy processes: a literature review. Working Paper 249. London: ODI; 2005.
40. WHO Regional Office for Africa (WHO/AFRO). Research for health: A strategy
for the African Region. Brazzaville: WHO/AFRO; 2015.
41. Cuervo LG. EQUATOR Network annual lecture on 30 September 2015.
Increasing value and reducing waste in biomedical research conference,
28–30 September 2015, Edinburgh, UK. http://issuu.com/luisgabrielcuervo/
docs/lgc_20150930_equator_annual_lecture.
42. PAHO. PAHO’s policy on research for health. Washington, DC: PAHO; 2010.
43. Sutcliff S, Court J. Evidence-based policymaking: What is it? How Does it
work? What relevance for developing countries? London: Overseas
Development Institute; 2005.
44. WHO Regional Office for Africa. Algiers Declaration on Research for Health.
Brazzaville: WHO/AFRO; 2008.
45. Feldman PH, Nadash P, Gursen M. Improving communication between
researchers and policy makers in long-term care: or, researchers are from
Mars; policy makers are from Venus. Gerontologist. 2001;41(3):312–21.
46. Mijumbi RM, Oxman AD, Panisset U, Sewankambo NK. Feasibility of a rapid
response mechanism to meet policymakers’ urgent needs for research
evidence about health systems in a low income country: a case study.
Implement Sci. 2014;9:114. http://www.implementationscience.com/
content/9/1/114.
47. WHO. Evidence-Informed-Policy Network (EVIPNet) 2012–2015 Strategic
Plan. Geneva: WHO; 2012.
Kirigia et al. BMC Health Services Research 2016, 16(Suppl 4):215 Page 313 of 366
48. PAHO. Support Tools for Evidence-Informed Policy-Making (STP): accessible
in four languages. http://bit.ly/SUPPORT_Tools. Accessed 17 Feb 2016.
49. COHRED. RHInnO Ethics Initiative https://www.youtube.com/
watch?v=nZK1KyWQKIo. Accessed 16 Feb 2016.
50. COHRED. Research Fairness Initiative. http://www.cohred.org/frc. Accessed
16 Feb 2016.
51. Musolino N, Lazdins J, Toohey J, IJsselmuiden C. COHRED Fairness Index for
international collaborative partnerships. Lancet. 2015;385:1293–4.
52. COHRED. http://cfi.cohred.org.
53. WHO. Standards and operational guidelines for ethics review of health-
related research with human participants. Geneva: WHO; 2011.
54. WHO. Operational guidelines for ethics committees that review biomedical
research. Geneva: WHO; 2000.
55. Motari M, Ota MMO, Kirigia JM. Readiness of ethics review systems for a
changing public health landscape in the WHO African Region. BMC Med
Ethics. 2015;16:82. http://www.biomedcentral.com/1472-6939/16/82.
56. WHO Regional Office for Africa. Implementation research guidelines for
immunization programme managers. Brazzaville: WHO/AFRO; 2014.
57. TDR. Geneva. http://www.who.int/tdr/about/en/. Accessed 16 Feb 2016.
58. Commission on Health Research for Development. Health Research – Essential
link to equity in development. Oxford: Oxford University Press; 1990.
59. Sambo LG, Kirigia JM, Orem JN. Health financing in the African Region:
2000–2009 data analysis. Int Arch Med. 2013;6:10. http://www.intarchmed.
com/content/6/1/10.
60. Nabyonga-Orem J. Diffusion of evidence into public health policies and
practice: investigating the black box, Thesis for Doctoral Degree in Public
Health. Brussels: UCL; 2015.
61. Federal Ministry of Health, Nigeria. High Level Ministerial Meeting on Health
Research in Africa: Communiqué, Abuja, Nigeria, 8–10 Mar 2006. Abuja: Federal
Government of Nigeria. https://healthresearchweb.org/en/africa/policies.
62. Ghana Ministry of Health. High Level Ministerial Meeting on Health
Research for Disease Control and Development: Communiqué, Accra,
Ghana, 15–17 June 2006. Accra: Government of Ghana https://
healthresearchweb.org/en/africa/policies. Accessed 10 March 2016.
63. Kirigia JM, Ota MO, Flavia S, Wiysonge CS, Mayosi BM. African health
research systems barometer. Unpublished report. Brazzaville: WHO Regional
Office for Africa; 2015.
64. African Academy of Sciences http://www.aasciences.org. Accessed 15 Jan 2016.
65. Association of African Universities. http://www.iau-hesd.net/en/organizations/
1963-association-african-universities-aau.html. Accessed 16 Feb 2016.
66. Inter-University Council of East Africa. URL: http://www.iucea.org/Accessed
16 Feb 2016.
67. Caplan N. The two-communities theory and knowledge utilization. Am
Behav Sci 1979;459–470.
68. Ongolo-Zogo P, Lavis JN, Tomson G, Sewankambo NK. Initiatives supporting
evidence informed health system policymaking in Cameroon and Uganda:
a comparative historical case study. BMC Health Serv Res. 2014;14:612.
http://www.biomedcentral.com/1472-6963/14/612.
69. COHRED. www.cohred.org. Accessed 17 Dec 2015.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Kirigia et al. BMC Health Services Research 2016, 16(Suppl 4):215 Page 314 of 366
